Skip to main content

How Democrats' drug price negotiations would work

   August 10, 2022

The legislation would allow Medicare to negotiate with manufacturers the costs of 10 pricey drugs in 2026, expanding to 20 before the end of the decade. There are constraints on which ones qualify, though: Drugs have to have been on the market for nearly a decade and have no competition.

Full story

Get the latest on healthcare leadership in your inbox.